Virtu Financial LLC Krystal Biotech, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$108.01 - $179.35 $388,727 - $645,480	3,599 New	3,599 $640,000
Q2 2023 Jul 27, 2023	BUY	$78.48 - $130.32 $177,286 - $294,392	2,259 New	2,259 $265,000
Q2 2020 Aug 07, 2020	SELL	$37.03 - $60.0 $219,217 - $355,200	-5,920 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$33.17 - $65.23 $196,366 - $386,161	5,920 New	5,920 $328,000

311

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.05B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.